Supramolecular β-cyclodextrin adducts of boron-rich DNA metallointercalators containing dicarba-closo-dodecaborane(12).

A chiral, isomeric series of novel boron-rich Pt(II) metallointercalators ([PtL2(phen)](NO3)2: L = (x)-(1,y-closo-carboran-1-yl)pyrid-z-ylmethanol: x = R, S; y = 7, 12; z = 3, 4) wre prepared and fully characterized. By means of variable-temperature NMR spectroscopy, different combinations of Δ-head-to-tail, head-to-head, and Λ-head-to-tail rotamers were identified, and the free energies of activation for Pt-N bond rotation were determined for the pyrid-4-yl complexes with ΔG(‡)307 = 16.1 ± 0.3 kcal mol(-1) and ΔG(‡)325 = 16.2 ± 0.5 kcal mol(-1) for the 1,7-carboranyl derivative and ΔG(‡)307 = 16.4 ± 0.5 kcal mol(-1) and ΔG(‡)325 = 16.2 ± 0.5 kcal mol(-1) for the 1,12-carboranyl derivative. The corresponding 2:1 host-guest β-cyclodextrin (β-CD) adducts ([PtL2(phen)·2β-CD](NO3)2) were also prepared and fully characterized by high resolution electrospray ionization mass spectrometry and 2D-(1)H{(11)B} nuclear Overhauser enhancement spectroscopy and rotating-frame Overhauser effect spectroscopy NMR experiments. The interaction of the novel supramolecular adducts with calf thymus DNA was investigated by means of linear dichroism, ultraviolet-visible spectroscopy, thermal denaturation, and isothermal titration calorimetry experiments which revealed a bimodal binding regime with DNA intercalation favored at low [drug]/[DNA] ratios, while at higher drug loading, surface aggregation was observed. Furthermore, the data were also consistent with some degree of dissociation of the β-CD host-guest adducts upon DNA binding. When we used a single binding-site model, interpreted as a weighted average of all of the possible equilibrium interactions, the compounds showed high affinity for ct-DNA with K(assoc) ranging from (1.3 ± 0.1) × 10(5) M(-1) to (5.7 ± 0.4) × 10(5) M(-1). In general, the overall DNA-binding behavior was enthalpically driven with a minor or unfavorable entropic component, which is consistent with the thermodynamics of an intercalation-dominated process. A higher degree of DNA intercalation was observed for the R-isomer in the pyrid-3-yl compounds, and the opposite trend was observed in the case of pyrid-4-yl derivatives.

[1]  M. Bhadbhade,et al.  Synthesis and supramolecular studies of chiral boronated platinum(II) complexes: insights into the molecular recognition of carboranes by β-cyclodextrin. , 2012, Chemistry.

[2]  J. Collins,et al.  A ternary supramolecular system containing a boronated DNA-metallointercalator, β-cyclodextrin and the hexanucleotide d(GTCGAC)2. , 2012, Chemical communications.

[3]  E. Hey‐Hawkins,et al.  Carbaboranes as pharmacophores: properties, synthesis, and application strategies. , 2011, Chemical reviews.

[4]  M. Kassiou,et al.  Boron in drug discovery: carboranes as unique pharmacophores in biologically active compounds. , 2011, Chemical reviews.

[5]  R. Vaitkus,et al.  Large inclusion constants of β-cyclodextrin with carborane derivatives , 2011 .

[6]  Yi Liang,et al.  Studies on thermodynamic nature of steroselectivity for ruthenium(II) polypyridyl complex binding to DNA , 2010 .

[7]  B. Lippert,et al.  (1)H NMR spectroscopic identification of binding modes of 2,2'-bipyridine ligands in complexes of square-planar d(8) metal ions. , 2009, Dalton transactions.

[8]  J. Aldrich-Wright,et al.  Diffusion-based studies on the self-stacking and nanorod formation of platinum(II) intercalators. , 2009, Chemical communications.

[9]  Y. Endo,et al.  Complexation of β-cyclodextrin with carborane derivatives in aqueous solution , 2008 .

[10]  S. Burgmayer,et al.  DNA binding by Ru(II)–bis(bipyridine)–pteridinyl complexes , 2008, JBIC Journal of Biological Inorganic Chemistry.

[11]  N. Moitessier,et al.  Platinum phenanthroimidazole complexes as G-quadruplex DNA selective binders. , 2008, Chemistry.

[12]  Thorsteinn Loftsson,et al.  Cyclodextrins as pharmaceutical solubilizers. , 2007, Advanced drug delivery reviews.

[13]  K. Sakurai,et al.  DNA binding of tilorone: 1H NMR and calorimetric studies of the intercalation. , 2007, Biochemistry.

[14]  J. Collins,et al.  DNA intercalators in cancer therapy: organic and inorganic drugs and their spectroscopic tools of analysis. , 2007, Mini reviews in medicinal chemistry.

[15]  J. Clegg,et al.  Synthesis and preliminary DNA-binding studies of diimineplatinum(II) complexes containing 3- or 4-pyridineboronic acid. , 2007, Dalton transactions.

[16]  J. Aldrich-Wright,et al.  Chiral Platinum(II) Metallointercalators with Potent in vitro Cytotoxic Activity , 2007, ChemMedChem.

[17]  L. Cronin,et al.  Microcalorimetry of interaction of dihydro-imidazo-phenanthridinium (DIP)-based compounds with duplex DNA. , 2007, Biophysical chemistry.

[18]  L. Rendina,et al.  Boronated DNA-binding compounds as potential agents for boron neutron capture therapy. , 2007, Mini reviews in medicinal chemistry.

[19]  J. Chaires,et al.  A thermodynamic signature for drug-DNA binding mode. , 2006, Archives of biochemistry and biophysics.

[20]  I. Butler,et al.  An Overview of 195Pt Nuclear Magnetic Resonance Spectroscopy , 2006 .

[21]  M. D. Di Pietro,et al.  DNA interaction of platinum(II) complexes with 1,10-phenanthroline and extended phenanthrolines. , 2006, Inorganic chemistry.

[22]  A. Velázquez‐Campoy.  Ligand binding to one-dimensional lattice-like macromolecules: analysis of the McGhee-von Hippel theory implemented in isothermal titration calorimetry. , 2006, Analytical biochemistry.

[23]  M. E. Williams,et al.  Tetraplatinated artificial oligopeptides afford high affinity intercalation into dsDNA. , 2005, Journal of the American Chemical Society.

[24]  L. Rendina,et al.  Synthesis and anti-cancer activity of dinuclear platinum(II) complexes containing bis(thioalkyl)dicarba-closo-dodecaborane(12) ligands. , 2005, Dalton transactions.

[25]  L. Rendina,et al.  A highly water-soluble platinum(ii) complex containing a thiopropyl-1,2-dicarba-closo-dodecaborane(12) ligand functionalised with a pendant glycerol group. , 2005, Dalton transactions.

[26]  L. Ji,et al.  Biophysical studies of a ruthenium(II) polypyridyl complex binding to DNA and RNA prove that nucleic acid structure has significant effects on binding behaviors , 2005, JBIC Journal of Biological Inorganic Chemistry.

[27]  L. Rendina,et al.  (2,2':6',2' '-Terpyridine)platinum(II) complexes containing (thioalkyl)dicarba-closo-dodecaborane(12) ligands. , 2005, Inorganic chemistry.

[28]  Mayank M. Patel,et al.  Contribution of hydrophobicity to thermodynamics of ligand-DNA binding and DNA collapse. , 2005, Biophysical journal.

[29]  A. Rodger,et al.  Micro-volume couette flow sample orientation for absorbance and fluorescence linear dichroism. , 2004, Biophysical journal.

[30]  J. Collins,et al.  DNA binding and biological activity of some platinum(II) intercalating compounds containing methyl-substituted 1,10-phenanthrolines. , 2004, Dalton transactions.

[31]  A. Rotondo,et al.  NMR Investigation and Dynamic Behaviour of [2,2′‐Bipyridylbis(pyridine)platinum(II)]2+ and Related Cationic Complexes − Crystal Structure of [Pt(bipy)(py)2](PF6)2 , 2003 .

[32]  N. Margiotta,et al.  Mono‐ and Bis‐Guanosine Adducts of Platinum Complexes with Carrier Ligands Having In‐Plane Steric Bulk: The Case of 1,10‐Phenanthroline and 2,9‐Dimethyl‐1,10‐phenanthroline , 2003 .

[33]  A. Rodger,et al.  Carbohydrate Derivatives of the Antitumour Alkaloid 9‐Hydroxyellipticine , 2003 .

[34]  L. Rendina,et al.  Synthesis and DNA-binding properties of cationic 2,2':6',2' '-terpyridineplatinum(II) complexes containing 1,2- and 1,7-dicarba-closo-dodecaborane(12). , 2002, Inorganic chemistry.

[35]  M. Threadgill,et al.  Formation of a remarkably robust 2:1 complex between beta-cyclodextrin and a phenyl-substituted icosahedral carborane. , 2002, Chemical communications.

[36]  E. Tiekink,et al.  A New Methodology for the Preparation of Cationic Organoplatinum(II) Complexes with Hydrogen-Bonding Functionality , 2001 .

[37]  B. Nordén,et al.  Linear and circular dichroism of drug-nucleic acid complexes. , 2001, Methods in enzymology.

[38]  D. Odom,et al.  Recognition and reaction of metallointercalators with DNA. , 1999, Chemical reviews.

[39]  P. Stang,et al.  Dynamics of noncovalent supramolecular complexes. NMR study of the rotational barriers in chiral BINAP palladium(II) and platinum(II) bis(phosphane) complexes that resemble the minimal subunits of chiral polygons and polyhedra , 1999 .

[40]  G. Arena,et al.  Interaction of organometallic cationic complex ions containing terpyridine ligands with nucleic acids: an investigation on aggregative phenomena , 1998 .

[41]  F. Hirayama,et al.  Cyclodextrin Drug Carrier Systems. , 1998, Chemical reviews.

[42]  R. Barth,et al.  The Chemistry of Neutron Capture Therapy. , 1998, Chemical reviews.

[43]  R. Eldik,et al.  Specific Chelate Tuning of the Substitution Kinetics of Platinum(II) Complexes in Aqueous Solution , 1998 .

[44]  M. D. Di Pietro,et al.  Noncovalent Interactions of Platinum(II) Square Planar Complexes Containing Ligands Out-of-Plane with DNA. , 1998, Inorganic chemistry.

[45]  R. Barth,et al.  Evaluation of in vitro cytotoxicity of carboranyl amino acids, their chemical precursors and nido carboranyl amino acids for boron neutron capture therapy. , 1995, Anticancer research.

[46]  J. Carlsson,et al.  Radiation dose heterogeneity in receptor and antigen mediated boron neutron capture therapy. , 1994, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[47]  D. McMillin,et al.  DNA-binding studies of Cu(bcp)2+ and Cu(dmp)2+: DNA elongation without intercalation of Cu(bcp)2+ , 1993 .

[48]  W. Kaim,et al.  Electrochemistry and spectroelectrochemistry (EPR, UV-visible-near-IR) of platinum(II) 2,2'-bipyridine and ring-metalated bipyridine complexes: PtII(L-) and PtI(L-) but not PtI(L) , 1992 .

[49]  F. Wimmer,et al.  Preparation and interconversion of dimeric di-µ-hydroxo and tri-µ-hydroxo complexes of platinum(II) and palladium(II) with 2,2′-bipyridine and 1,10-phenanthroline , 1989 .

[50]  A. Harada,et al.  Preparation and properties of inclusion complexes of 1,2-dicarbadodecaborane(12) with cyclodextrins , 1988 .

[51]  D. Crothers,et al.  Studies on interaction of anthracycline antibiotics and deoxyribonucleic acid: equilibrium binding studies on interaction of daunomycin with deoxyribonucleic acid. , 1982, Biochemistry.

[52]  R. L. Baldwin,et al.  Cation-induced toroidal condensation of DNA studies with Co3+(NH3)6. , 1980, Journal of molecular biology.

[53]  A. Hazell,et al.  The cyanobis(1,10-phenanthroline)platinum(II) complex in aqueous solution and as the crystalline nitrate. Nuclear magnetic resonance measurements and crystal-structure determination , 1980 .

[54]  J. McGhee.  Theoretical calculations of the helix–coil transition of DNA in the presence of large, cooperatively binding ligands , 1976, Biopolymers.

[55]  J. Schellman,et al.  Compact form of DNA induced by spermidine , 1976, Nature.

[56]  S. Lippard,et al.  Metallointercalation reagents. 2-hydroxyethanethiolato(2,2',2'-terpyridine)-platinum(II) monocation binds strongly to DNA by intercalation. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[57]  P. V. von Hippel,et al.  Theoretical aspects of DNA-protein interactions: co-operative and non-co-operative binding of large ligands to a one-dimensional homogeneous lattice. , 1974, Journal of molecular biology.

[58]  D. Crothers.  Statistical thermodynamics of nucleic acid melting transitions with coupled binding equilibria , 1971, Biopolymers.